Codexis (CDXS) Enterprise Value (2010 - 2026)
Codexis' (CDXS) quarterly Enterprise Value came in at -$65.1 million in Q1 2026, down 8.9% year-on-year from -$71.5 million in Q1 2025, and up 16.71% quarter-over-quarter from -$78.2 million in Q4 2025.
Codexis (CDXS) Enterprise Value (2010 - 2026) Analysis & Trends
Codexis' Enterprise Value history runs 17 years deep, the most recent figure standing at -$65.1 million for Q1 2026.
- On a quarterly basis, Enterprise Value fell 8.9% year-over-year to -$65.1 million in Q1 2026; TTM through Mar 2026 was -$65.1 million, a 8.9% decrease from a year earlier, with the FY2025 full-year figure at -$78.2 million, down 6.46% from the prior year.
- Enterprise Value advanced to -$65.1 million in Q1 2026 per CDXS's latest filing, from -$78.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$2.1 million in Q1 2022 and bottomed at -$114.0 million in Q4 2022.
- The 5-year median for Enterprise Value is -$66.3 million (2025), against an average of -$70.0 million.
- Biggest YoY gain for Enterprise Value was 98.51% in 2022; the steepest drop was 5075.67% in 2022.
- Year by year, Enterprise Value stood at -$114.0 million in 2022, then soared by 42.87% to -$65.1 million in 2023, then dropped by 12.82% to -$73.5 million in 2024, then decreased by 6.46% to -$78.2 million in 2025, then advanced by 16.71% to -$65.1 million in 2026.
- Per Business Quant, the three latest CDXS Enterprise Value figures stand at -$65.1 million (Q1 2026), -$78.2 million (Q4 2025), and -$58.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn | -65.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.14 Mn |
| Dec 31, 2025 | -78.21 Mn |
| Sep 30, 2025 | -58.75 Mn |
| Jun 30, 2025 | -66.33 Mn |
| Mar 31, 2025 | -59.82 Mn |
| Dec 31, 2024 | -73.46 Mn |
| Sep 30, 2024 | -54.38 Mn |
| Jun 30, 2024 | -56.18 Mn |
| Mar 31, 2024 | -29.08 Mn |
| Dec 31, 2023 | -65.12 Mn |
| Sep 30, 2023 | -74.58 Mn |
| Jun 30, 2023 | -92.09 Mn |
| Mar 31, 2023 | -102.83 Mn |
| Dec 31, 2022 | -113.98 Mn |
| Sep 30, 2022 | -108.69 Mn |
| Jun 30, 2022 | -90.11 Mn |
| Mar 31, 2022 | -2.09 Mn |
| Dec 31, 2021 | -116.80 Mn |
| Sep 30, 2021 | -2.10 Mn |
| Jun 30, 2021 | -2.10 Mn |